Compare DexCom, Inc. (DXCM) vs PepsiCo, Inc. (PEP) Price & Performance

DexCom, Inc.Trade

PepsiCo, Inc.Trade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs PepsiCo, Inc. — how do they compare? DexCom, Inc. trades at $77.86 (market cap $28.06B), while PepsiCo, Inc. trades at $138.47 (market cap $184.81B). The key difference: PepsiCo, Inc. is far larger — about 6.6× DexCom, Inc.'s market cap, and PepsiCo, Inc. pays a 4.37% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.

	DXCM	PEP
Market Cap	$28.06B	$184.81B
Sector	Health	Consumer Staples
52-Week High	$89.53	$170.44
52-Week Low	$54.84	$135.35
Enterprise Value	$27.03B	$227.30B
Dividend Yield	—	4.37%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DexCom, Inc.

DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.

The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.

PepsiCo, Inc.

PepsiCo (PEP) trades at $135.45, down 2.2% on the day, with technical indicators showing bearish momentum despite recent earnings beats. The stock faces pressure from consumer resistance to snack price increases, with recent news highlighting price cuts of up to 15% on products like Doritos. Fundamentally, PEP maintains strong profitability with a 10.78% net margin and 51.59% ROE, though 2025 revenue growth slowed to 2.2% year-over-year. Analyst consensus remains positive with a $159.27 price target, representing 17.6% upside potential from current levels.

The investment case balances strong cash flow generation and dividend reliability against volume sensitivity to pricing actions. Near-term performance hinges on Q1 2026 results due next week, where investors will scrutinize North American recovery trends. While valuation appears reasonable at 17.75x P/E, execution risks around price optimization and competitive pressures warrant monitoring. The current technical weakness may present entry opportunities for long-term investors seeking stable consumer staples exposure.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DXCM

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trendsCustom Market Insights · 2 days agoBullish View details →

PEP

U.S. grocery sales drop as shoppers buy less despite rising prices, shifting focus to promotions and value.CNBC · 8 hours agoBearish PepsiCo rated strong buy with 13.7-18.2% growth forecast, driven by dividends, EPS, and undervaluation.Seeking Alpha · 10 hours agoBullish SCHD ETF outperforms S&P 500 with nearly 2% return in a month and attractive undervalued holdings.Seeking Alpha · 2 days agoBullish View details →

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

About PepsiCo, Inc.

PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.